FI102834B1 - Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä - Google Patents
Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissäInfo
- Publication number
- FI102834B1 FI102834B1 FI915649A FI915649A FI102834B1 FI 102834 B1 FI102834 B1 FI 102834B1 FI 915649 A FI915649 A FI 915649A FI 915649 A FI915649 A FI 915649A FI 102834 B1 FI102834 B1 FI 102834B1
- Authority
- FI
- Finland
- Prior art keywords
- peptides
- cysteine thiol
- immunological assays
- protected peptides
- thiol protected
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- DJQYYYCQOZMCRC-UHFFFAOYSA-N 2-aminopropane-1,3-dithiol Chemical compound SCC(N)CS DJQYYYCQOZMCRC-UHFFFAOYSA-N 0.000 title abstract 2
- 238000010324 immunological assay Methods 0.000 title 1
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241001430294 unidentified retrovirus Species 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 abstract 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 abstract 1
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36051389A | 1989-06-02 | 1989-06-02 | |
| US36051389 | 1989-06-02 | ||
| US9003148 | 1990-06-04 | ||
| PCT/US1990/003148 WO1990015071A1 (en) | 1989-06-02 | 1990-06-04 | Cysteine thiol-protected peptides for use in immunoassays |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI915649A0 FI915649A0 (fi) | 1991-11-29 |
| FI102834B1 true FI102834B1 (fi) | 1999-02-26 |
| FI102834B FI102834B (fi) | 1999-02-26 |
Family
ID=23418295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI915649A FI102834B (fi) | 1989-06-02 | 1991-11-29 | Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrity ksissä |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0474789B1 (da) |
| JP (1) | JP3404035B2 (da) |
| KR (1) | KR960013600B1 (da) |
| AT (1) | ATE162799T1 (da) |
| AU (1) | AU652919B2 (da) |
| CA (1) | CA2056381C (da) |
| DE (1) | DE69032009T2 (da) |
| DK (1) | DK0474789T3 (da) |
| ES (1) | ES2113860T3 (da) |
| FI (1) | FI102834B (da) |
| NO (1) | NO304151B1 (da) |
| WO (1) | WO1990015071A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008044A (en) * | 1989-08-24 | 1999-12-28 | Bioclonetics | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC) |
| US6083504A (en) * | 1989-08-24 | 2000-07-04 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| US5459060A (en) * | 1989-08-24 | 1995-10-17 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| EP0438332B1 (fr) * | 1990-01-16 | 1998-04-08 | Orgenics Ltd. | Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA |
| CA2387666A1 (en) * | 1999-10-27 | 2001-05-03 | Innogenetics N.V. | Redox reversible hcv proteins with native-like conformation |
| JP5182069B2 (ja) * | 2008-12-24 | 2013-04-10 | Ｊｎｃ株式会社 | チオール基を有する刺激応答性磁性微粒子及びその利用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4111924A (en) * | 1976-01-05 | 1978-09-05 | Takeda Chemical Industries, Ltd. | Method for removal of thiol-protecting groups |
| FR2525592B1 (da) * | 1982-04-26 | 1984-09-14 | Pasteur Institut | |
| US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
| DE3788397T3 (de) * | 1986-03-24 | 2003-11-27 | Ortho Pharmaceutical Corp., Raritan | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. |
| EP0247557B1 (en) * | 1986-05-27 | 1994-04-20 | F. Hoffmann-La Roche Ag | HTLV-III(LAV) Envelope peptides |
| GB8828097D0 (en) * | 1988-12-01 | 1989-01-05 | Wellcome Found | Peptides |
-
1990
- 1990-06-04 DE DE69032009T patent/DE69032009T2/de not_active Expired - Fee Related
- 1990-06-04 KR KR1019910701744A patent/KR960013600B1/ko not_active IP Right Cessation
- 1990-06-04 WO PCT/US1990/003148 patent/WO1990015071A1/en active IP Right Grant
- 1990-06-04 JP JP51045090A patent/JP3404035B2/ja not_active Expired - Lifetime
- 1990-06-04 DK DK90911054T patent/DK0474789T3/da active
- 1990-06-04 EP EP90911054A patent/EP0474789B1/en not_active Expired - Lifetime
- 1990-06-04 CA CA002056381A patent/CA2056381C/en not_active Expired - Lifetime
- 1990-06-04 AU AU60532/90A patent/AU652919B2/en not_active Expired
- 1990-06-04 ES ES90911054T patent/ES2113860T3/es not_active Expired - Lifetime
- 1990-06-04 AT AT90911054T patent/ATE162799T1/de not_active IP Right Cessation
-
1991
- 1991-11-29 NO NO914725A patent/NO304151B1/no not_active IP Right Cessation
- 1991-11-29 FI FI915649A patent/FI102834B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69032009T2 (de) | 1998-07-23 |
| ES2113860T3 (es) | 1998-05-16 |
| JP3404035B2 (ja) | 2003-05-06 |
| NO914725L (no) | 1992-01-29 |
| NO914725D0 (no) | 1991-11-29 |
| FI102834B (fi) | 1999-02-26 |
| FI915649A0 (fi) | 1991-11-29 |
| JPH04505623A (ja) | 1992-10-01 |
| CA2056381A1 (en) | 1990-12-03 |
| CA2056381C (en) | 2000-08-22 |
| KR960013600B1 (ko) | 1996-10-09 |
| DE69032009D1 (de) | 1998-03-05 |
| AU652919B2 (en) | 1994-09-15 |
| ATE162799T1 (de) | 1998-02-15 |
| EP0474789A1 (en) | 1992-03-18 |
| EP0474789B1 (en) | 1998-01-28 |
| AU6053290A (en) | 1991-01-07 |
| NO304151B1 (no) | 1998-11-02 |
| DK0474789T3 (da) | 1998-09-28 |
| WO1990015071A1 (en) | 1990-12-13 |
| KR920701236A (ko) | 1992-08-11 |
| EP0474789A4 (en) | 1992-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI870447A (fi) | Htlv-iii-hoeljepeptider. | |
| PT90574A (pt) | Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma | |
| EA200100943A1 (ru) | Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител | |
| SE8704185L (sv) | Nya peptider, artificiella antigener och immunoanalystestsatser | |
| KR900700507A (ko) | Htlv-1 감염 검출용 합성 펩티드 항원 | |
| BR9106220A (pt) | Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c. | |
| EP0284587A3 (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
| FI102834B1 (fi) | Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä | |
| ES2080047T3 (es) | Peptidos hiv y metodos para la deteccion de hiv. | |
| ATE119203T1 (de) | Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. | |
| ATE116660T1 (de) | Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1. | |
| ES2058259T5 (es) | Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2. | |
| ATE109158T1 (de) | Rubella-e1 und c peptide. | |
| GR900100608A (el) | Κυστέϊνο ?ειολο-προστατευμένα πεπτίδια γιά χρήση σε ανοσοδοκιμασίες. | |
| Blake et al. | Cysteine thiol-protected peptides for use in immunoassays | |
| ES2129358A1 (es) | Procedimiento de deteccion en una sola prueba de anticuerpos anti-virus de la hepatitis c, de la inmunodeficiencia humano y antigeno de superficie del virus de la hepatitis b". |